Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s):  CSCI

Healthcare Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CSCI)

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

GlobeNewswire November 12, 2024

COSCIENS Biopharma Announces Change to Board of Directors

GlobeNewswire October 8, 2024

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

GlobeNewswire October 1, 2024

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

GlobeNewswire September 23, 2024

COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire August 27, 2024

COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

GlobeNewswire August 13, 2024

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

GlobeNewswire August 6, 2024

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

GlobeNewswire July 16, 2024

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire June 13, 2024
View More News ››

Opinion & Analysis (TSX:CSCI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CSCI)

Remember Ceapro's PGX Strips That Could Deliver Sublingual?

Two Cannabis companies choose an alternate method..  THC-infused oral pouches, https://stratcann.com/news/canadian-cannabis...
archeo753 - 5 days ago

RE:RE:RE:RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Thank you BoazThorn appreciate another no woke person having his voice heard.People like Tropicalsun just do not get it but then he was...
Hopeforthebest - 9 days ago

RE:RE:RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Hopeforthebest, Dude I could not agree with you more. I too have been harping about Gilles for years and do you know why? Gilles is the...
BoazKhorn - 9 days ago

RE:RE:RE:Email Response from Gilles Gagnon on March 12, 2024

tropicalsun, your woke additude has clouded to ability to think logical to the point that your eyes are turning brown. I will NOT stop...
Hopeforthebest - 10 days ago

RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Hopefortherestofus and peace and quiet if you would just fade off into the sunset with your none stop posting about Gilles Gagnon. I...
Tropicalsun - 11 days ago

RE:RE:Email Response from Gilles Gagnon on March 12, 2024

I wouldn't call him a failure. I'd say he's a successful conman.
scarface9 - 11 days ago
View more Bullboard ››

ReGen III Corp.

ReGen III Corp.

ReGen III Corp. is a Canada-based cleantech company commercializing its ReGen, patented technology to recycle used motor oil ...
View More »